Ciphergen Biosystems(CIPH): Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH):

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (215)	4/2/2004 1:01:49 AM
From: mopgcw	Read Replies (1) of 510

Piper wrap-up on AACR indicated that them meeting was dominated again by Biomarkers and pharmacogenomic markers. They also noted that they believe bimarker research to remain an important driver for the mass spec mrkt and view ciph to be the pure play in the space. They are comfy with their $81.5mm rev est for the year and note the hiring of 5 program managers/hiring in europe and buy-out of their Japan sales force. system demos are up significantly and appear to have been successful winning several lost 4q03 system placements. fwiw. regards, george

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next